You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 6,699,498


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,699,498
Title: Transdermal therapeutic systems having improved stability and their production
Abstract:This invention provides for, inter alia, a transdermal therapeutic system comprising at least one therapeutically active substance, which is oxidizable by hydroperoxides, wherein the amount of oxidative degradation of said active substances(s) and the corresponding formation of oxidative degradation products is reduced, which comprises one or more constituents of said transdermal therapeutic system being in contact with said active substance(s), wherein the sum of the peroxide number(s) (PON) of each of said constituents related to their percentage of the whole amount of said constituents as expressed by the formula ##EQU1## where N is the percentage content of the whole amount of said constituents in the TTS, n is the number of said constituents in the TTS, i is the running number PON is the peroxide number of each of the constituents, is not greater than 20.
Inventor(s): Muller; Walter (Neuwied, DE)
Assignee: LTS Lohmann Therapie-Systeme AG (Andernach, DE)
Application Number:09/723,130
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,699,498
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,699,498: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 6,699,498, titled "Transdermal Therapeutic Systems Having Improved Stability and Their Production," and provide a detailed analysis of its claims and the broader patent landscape.

Background of the Patent

Patent Overview

United States Patent 6,699,498 was issued on March 2, 2004, and it pertains to transdermal therapeutic systems with improved stability. These systems are designed to deliver medications through the skin, a method that has gained significant attention for its convenience and efficacy.

Inventors and Assignees

The patent was granted to the inventors who developed the specific formulation and production methods for these transdermal systems. Understanding the assignees and inventors can provide insights into the potential applications and the companies involved in the development and commercialization of the technology.

Claims Analysis

Independent Claims

The independent claims of a patent define the broadest scope of the invention. For U.S. Patent 6,699,498, these claims typically include the composition of the transdermal system, the method of preparation, and the specific improvements that enhance stability.

Dependent Claims

Dependent claims narrow down the scope of the invention by adding specific limitations to the independent claims. These claims might include particular ratios of ingredients, specific manufacturing steps, or additional features that enhance the stability or efficacy of the transdermal system.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is crucial for determining the scope of protection and for assessing potential infringement. The claims of U.S. Patent 6,699,498 would be analyzed in the context of the specification and the prior art to understand their precise meaning and scope[3].

Patent Scope and Measurements

Patent Scope

The scope of a patent is determined by the claims and is a critical factor in understanding what is protected and what is not. For U.S. Patent 6,699,498, the scope would include all transdermal therapeutic systems that fall within the described composition and method of preparation.

Patent Scope Measurements

The USPTO's Patent Claims Research Dataset provides tools to measure patent scope, including claim-level statistics and document-level statistics. These measurements can help in understanding the breadth and depth of the patent's protection[3].

Prior Art and Citation Analysis

Prior Art Search

Conducting a thorough prior art search is essential to understand the novelty and non-obviousness of the invention. Tools like the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD) can be used to identify relevant prior art and citations related to U.S. Patent 6,699,498[1].

Citation Analysis

Citation analysis involves examining the citations received by the patent and those it cites. This can provide insights into the patent's impact and its position within the broader patent landscape. The CCD application consolidates citation data from multiple offices, making it easier to visualize the citation network[1].

International Patent Landscape

Global Patent Search

To assess the global impact and protection of U.S. Patent 6,699,498, it is necessary to search international patent databases. Resources like the European Patent Office's esp@cenet, the Japan Patent Office, and WIPO's PATENTSCOPE provide access to international patent applications and granted patents[1][4].

Machine Translation

Machine translation tools available through these databases can help in understanding patents in different languages, facilitating a more comprehensive global analysis.

Patent Assignment and Ownership

Patent Assignment Search

The Patent Assignment Search tool allows users to track changes in ownership of U.S. Patent 6,699,498. This is crucial for understanding the current assignee and any potential licensing or collaboration agreements[1].

Public Search Facilities and Resources

USPTO Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, and the Patent and Trademark Resource Centers (PTRCs) provide access to patent and trademark information. These resources can be invaluable for conducting detailed searches and seeking expert assistance[1].

Training and Tutorials

The USPTO offers various training materials and tutorials, including the Patent Public Search tutorial, to help users conduct effective patent searches. These resources are particularly useful for those new to patent searching[1][4].

Infringement and Litigation

Infringement Analysis

To determine if another product or process infringes on U.S. Patent 6,699,498, a detailed comparison of the claims with the potentially infringing product is necessary. This involves analyzing the composition, method of preparation, and any other relevant aspects covered by the claims.

Litigation Examples

Cases like UCB, Inc. v. Actavis Labs. UT, Inc. illustrate the importance of claim construction and infringement analysis in patent litigation. Understanding these cases can provide insights into how courts interpret patent claims and determine infringement[2].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Prior Art: Conducting a thorough prior art search is essential for assessing novelty and non-obviousness.
  • International Landscape: Searching international patent databases helps in understanding global protection and impact.
  • Ownership: Tracking changes in ownership through patent assignment searches is vital for licensing and collaboration.
  • Resources: Utilizing public search facilities and training resources can enhance the effectiveness of patent searches.

FAQs

Q: How do I conduct a preliminary U.S. patent search?

A: You can use the USPTO's Patent Public Search tool, which provides enhanced access to prior art. Additionally, resources like the USPTO Public Search Facility and PTRCs offer training and assistance[1].

Q: What is the significance of the Common Citation Document (CCD)?

A: The CCD consolidates citation data from multiple offices, enabling users to visualize the citation network for a patent application on a single page[1].

Q: How can I determine if a product infringes on U.S. Patent 6,699,498?

A: You need to compare the claims of the patent with the potentially infringing product, analyzing aspects such as composition and method of preparation.

Q: What resources are available for searching international patent databases?

A: Resources include the European Patent Office's esp@cenet, the Japan Patent Office, and WIPO's PATENTSCOPE, which provide access to international patent applications and granted patents[1][4].

Q: Where can I find detailed information on patent claims and scope measurements?

A: The USPTO's Patent Claims Research Dataset provides detailed information on claims and scope measurements, including claim-level and document-level statistics[3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. UCB, Inc. v. Actavis Labs. UT, Inc.: https://case-law.vlex.com/vid/ucb-inc-v-actavis-884823502
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Clemson University - Advanced Patent Searching: https://clemson.libguides.com/advanced_patent_searching
  5. Patent Docs - September 7, 2014: https://www.patentdocs.org/2014/09/07/index.html

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,699,498

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,699,498

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 57 401Nov 29, 1999
Germany100 54 713Nov 04, 2000

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.